Search

everythinglearnresearchcommunity

for

Search:↓

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Dutasteride effectively treats hair loss and prostate issues.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.

Plant-based compounds show promise for treating neurodegenerative diseases but need more research.

Dutasteride is the most effective for hair loss but may cause sexual and mental side effects.

Applying a special compound can promote hair growth without harmful side effects.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Dutasteride works better than finasteride for hair growth with similar side effects.

Precision neuromodulation may improve schizophrenia symptoms.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.